$QSAM Perfectly positioned. Opportunity to launch improved drug of another already FDA approved. Same doctors who developed FDA approved cancer drug Quadramet now developing improved version in Cyclosam. Fast track potential. Clean cap structure.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.